Meeting
2023 ASCO Annual Meeting
Efficacy of paxman scalp cooling system at lower temperatures for prevention of anthracycline associated chemotherapy induced alopecia.
Authors
Shari Beth Goldfarb
Memorial Sloan Kettering Cancer Center, New York, NY
Shari Beth Goldfarb , Stephanie Gu , Nicolas Toumbacaris , Yuan Chen , Nadia Abdo , Analisa Dacunto , Victoria Susana Blinder , Monica N. Fornier , Cassandra Chang , Mario E. Lacouture
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Palliative Care and Symptom Management
Clinical Trial Registration Number
NCT04180579
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 12108)
DOI
10.1200/JCO.2023.41.16_suppl.12108
Abstract #
12108
Poster Bd #
476
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Polymorphism rs4673 and plasma paraoxonase 1 level for prediction and early diagnosis of anthracycline-mediated cardiotoxicity in patients with breast cancer.
First Author: Dmitry Yu. Gvaldin
Poster
2019 ASCO Annual Meeting
Safety, tolerability, and PK of topical calcitriol formulation for treatment of chemotherapy-induced alopecia (CIA) in patients receiving taxane-based regimen: Final results.
First Author: Mario E. Lacouture
Poster
2017 ASCO Annual Meeting
Scalp Cooling Alopecia Prevention trial (SCALP) for patients with early stage breast cancer.
First Author: Julie R. Nangia
Poster
2016 ASCO Annual Meeting
Topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Efficacy findings from a phase I safety study.
First Author: Mario E. Lacouture